Foxp3 expression in lesions of the different clinical forms of American tegumentary leishmaniasis

Parasite Immunology

Volumn 31, Issue 10, 2009, Pages 646-651

  Carneiro, F P ^a   De MagalhAes A V ^a   DeJesus Abreu Almeida Couto, M ^b   Bocca, A L ^a   Muniz Junqueira, M I ^a   Ribeiro Sampaio, R N ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b University of Maranhão   (Brazil)

Author keywords

Foxp3; Leishmaniasis; Regulatory T cell

Indexed keywords

CASPASE 3; FAS LIGAND; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; AGED; AMERICAN TEGUMETARY LEISHMANIASIS; ARTICLE; CD4[+] T LYMPHOCYTE; CHILD; CONTROLLED STUDY; DIFFUSE CUTANEOUS LEISHMANIASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LEISHMANIASIS; LOCALIZED CUTANEOUS LEISHMANIASIS; MALE; MUCOCUTANEOUS LEISHMANIASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; ANIMALS; APOPTOSIS; CASPASE 3; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FAS LIGAND PROTEIN; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; LEISHMANIASIS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 70349151271     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01148.x     Document Type: Article

References (28)

1. Convit J, Ulrich M, Fernández CT, et al. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1993 87 : 444 448.
2. Silveira FT, Lainson R Corbett CE. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Mem Inst Oswaldo Cruz 2004 99 : 239 251.
3. Grimaldi G Jr. Tesh RB. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 1993 6 : 230 250.
4. Bogdan C Rollinghoff M. The immune response to Leishmania: mechanisms of parasite control and evasion. Int J Parasitol 1998 28 : 121 134.
5. Carvalho EM, Johnson WD, Barreto E, et al. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol 1985 135 : 4144 4148.
6. Jonuleit H Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003 171 : 6323 6327.
7. Hori S, Nomura T Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 1061.
8. Tang Q Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008 9 : 239 244.
9. Askenasy N, Kaminitz A Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun Rev 2008 7 : 370 375.
10. Belkaid Y Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005 6 : 353 360.
11. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002 420 : 502 507.
12. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007 7 : 875 888.
13. Xu D, Liu H, Komai-Koma M, et al. CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol 2003 170 : 394 399.
14. Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS Belkaid Y. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 2006 203 : 777 788.
15. Ji J, Masterson J, Sun J Soong L. CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 2005 174 : 7147 7153.
16. Campanelli AP, Roselino AM, Cavassani KA, et al. CD4+ CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 2006 193 : 1313 1322.
17. Peters N Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 2006 213 : 159 179.
18. de Paula CD, Sampaio JH, Cardoso DR Sampaio RN. A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20 mgSbV/day for 20 days to treat cutaneous leishmaniasis. Rev Soc Bras Med Trop 2003 36 : 365 371.
19. Horita LG. UnBVision: Uma Solução Para a Análise e Tratamento de Imagens Digitais. Ciências da Computação, Instituto de Ciências Exatas da Universidade de Brasília, 2001.
20. Diaz NL, Zerpa O, Ponce LV, Convit J, Rondon AJ Tapia FJ. Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion. Exp Dermatol 2002 11 : 34 41.
21. Sugiyama H, Gyulai R, Toichi E, et al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005 174 : 164 173.
22. Verhagen J, Akdis M, Traidl-Hoffmann C, et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006 117 : 176 183.
23. de Boer OJ, van der Loos CM, Teeling P, van der Wal AC Teunissen MB. Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses. J Histochem Cytochem 2007 55 : 891 898.
24. Allan SE, Broady R, Gregori S, et al. CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev 2008 223 : 391 421.
25. Lindoso JA, Barbosa RN, Posada-Vergara MP, et al. Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World. Br J Dermatol 2009 160 : 311 318.
26. Mattos M, Caiza A, Fernandes O, et al. American cutaneous leishmaniasis associated with HIV infection: report of four cases. J Eur Acad Dermatol Venereol 1998 10 : 218 225.
27. Sampaio RN, Salaro CP, Resende P de Paula CD. American cutaneous leishmaniasis associated with HIV/AIDS: report of four clinical cases. Rev Soc Bras Med Trop 2002 35 : 651 654.
28. Yolcu ES, Ash S, Kaminitz A, Sagiv Y, Askenasy N Yarkoni S. Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunol Cell Biol 2008 86 : 650 658.